Tianlong and KHB Visit Key Vietnam Hospital to Accelerate Molecular Diagnostics Expansion
Release Date 2026-04-14

Tianlong & KHB sales teams and technical support team leaders recently visited a key hospital in Vietnam currently using the Polaris c1000 biochemistry analyser from our parent company, Kehua Bio-Engineering Co., Ltd. (KHB). The visit confirmed strong clinical recognition of the system’s reliability and performance in routine workflows, further strengthening confidence in KHB’s established diagnostic solutions.

未命名.png

Building on this foundation of trust and proven performance, our partner is now expanding collaboration with Tianlong into molecular diagnostics. With a strong interest in our PCR solutions, including blood screening, HBV, and HCV detection, both sides are moving toward a broader, long-term partnership—combining KHB’s biochemistry strengths with Tianlong’s molecular expertise.

123.png

Through this collaboration, Tianlong continues to deepen its presence in Vietnam, strengthen local partnerships, and deliver high-quality solutions to support the advancement of diagnostic capabilities. Tianlong remains committed to delivering integrated diagnostic solutions and supporting our partners in advancing precision diagnostics.



Share
Recommendation